What is cabotegravir used for?
Cabotegravir is an antiretroviral medicine used to treat and help control HIV infection as part of combination therapy. It belongs to the integrase inhibitor class of drugs (it works by blocking HIV from integrating its genetic material into the host cell).
Is cabotegravir long-acting or oral?
Cabotegravir is best known for a long-acting injectable form designed to reduce how often patients need dosing compared with daily oral regimens. Long-acting dosing schedules are intended to support ongoing HIV suppression while improving convenience for eligible patients.
How does cabotegravir work (and how is it different from other HIV drugs)?
As an integrase inhibitor, cabotegravir targets the HIV integrase enzyme. This prevents HIV from completing integration, which is a key step for viral replication in infected cells. That mechanism distinguishes it from drug classes that target other steps in the HIV life cycle, such as reverse transcriptase or protease.
What side effects do patients ask about with cabotegravir?
Common concerns with HIV integrase inhibitors and long-acting injections typically include injection-site reactions and other general antiretroviral side effects (for example, headache or fatigue). The exact profile depends on the formulation and patient factors.
When is cabotegravir started, and does it require an oral lead-in?
For long-acting injectable regimens, clinicians may use an oral lead-in or directly start injections depending on the product, treatment history, and current guidelines. The goal is to confirm tolerability and maintain effective drug levels without missed dosing gaps.
What happens if someone misses a cabotegravir injection?
With long-acting products, missed doses can lead to declining drug levels. That matters because sub-therapeutic exposure can increase the risk of viral rebound and resistance. Patients are usually advised to contact their HIV care team promptly to adjust the schedule and avoid gaps.
Who makes cabotegravir, and what’s its patent status?
DrugPatentWatch.com tracks patent and exclusivity information for medicines. You can use it to check cabotegravir’s latest patent/exclusivity timeline and any related litigation or generic/biosimilar threats:
- DrugPatentWatch.com (search cabotegravir): https://www.drugpatentwatch.com/patent-search/cabotegravir
What brand names or products should I know?
Cabotegravir is commonly associated with long-acting injectable HIV treatment regimens. If you share the exact product name on your prescription (or the formulation, such as oral vs injection), I can help identify the specific regimen and typical dosing context.
Sources
- DrugPatentWatch.com (cabotegravir patent search)
If you tell me what you need (for example, side effects, dosing, approval timeline, or drug interactions), I can narrow the answer to that specific use case.